$BNED: Why Barnes & Noble Education Stock Gained 42.6% in January

Date: Monday, February 11th, 2019

Stock(s) mentioned:

Source: Motley Fool (https://www.fool.com)

Summary: Shares of Barnes & Noble Education (NYSE:BNED) gained 42.6% in January, according to data from S&P Global Market Intelligence. The company’s stock fell …

Full article address: https://www.fool.com/investing/2019/02/11/why-barnes-noble-education-stock-gained-426-in-jan.aspx

Related News:

$BNED: Barnes & Noble Education Announces Expanded Library of Digital …

$BNED: Retiring Later, Paying Off Student Loan Debt – College Ave Student …

$BNED: Is It Time To Consider Buying Barnes & Noble Education, Inc. (NYSE …

$BNED: Barnes & Noble Education Expands Relationship with WW Norton …

$BNED: College Ave Student Loans Survey Finds Families Split on Whether …

$BNED: Barnes & Noble Education and SAGE Publishing Partner to Increase …

$BNED: Barnes & Noble Education (BNED) Q3 2019 Earnings Conference …

$BNED: Why Barnes & Noble Education Stock Plunged 32% Today

$GE $ALGN $BNED: Why General Electric, Align Technology, and Barnes & Noble …

$BNED: Barnes & Noble Education, Inc (BNED) CEO Mike Huseby on Q3 …

$BNED: Textbook pain sends Barnes & Noble Education down 30%

Latest News:

$SPY $BABA: If a popular options strategy suddenly implodes, be ready to scoop up cheap blue chips

$GE: Is General Electric a Buy?

$HD $URBN: Home Depot, Target, HP, Best Buy and More Major Earnings …

$TMUS: Masayoshi Son: Genius or insane? Maybe neither

$DAL $ALK $LUV $NFLX $UAL: Delta’s test of free in-flight Wi-Fi may shame other airlines into offering service

$AVTR $FSLY $LK $LYFT $PINS $UBER: Why the IPO Boom Will Continue

$SBUX: Millions of Americans Could Miss Work Tomorrow After the ‘Game of Thrones’ Finale

$AMZN $OXY $APC $WFC $SRE: Want to invest like Warren Buffett? Here are the ins and outs of buying preferred stock

$TSLA $GM: Tesla fires could dampen electric car sales as industry ramps up EV production, auto analysts say

$ROKU $GH $CVNA: 3 Stocks That Have Doubled in 2019 — Are They Still Buys?

$AXSM: Here’s Why You’ll Regret Ignoring This Biotech Stock Rocket